Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2026
Helus Pharma appoints Dr. Suresh Durgam to Board of Directors
Helus Pharma Inc. (Nasdaq: HELP), a clinical-stage pharmaceutical company, announced on October 15, 2026 the appointment of Suresh Durgam, M.D., to its Board of Directors. Durgam, a CNS drug-development executive and former Executive Vice President and Chief Medical Officer of Intra-Cellular Therapies, previously served on Helus Pharma's Scientific Advisory Board. The appointment is subject to approval of Cboe Canada.
2021
Cybin partners with Kernel to use Flow technology in clinical work
Cybin announced an agreement with Kernel to use Kernel's Flow neuroimaging technology for Cybin's upcoming sponsored clinical work.
2020
Cybin announces Clarmin Explorations' first-quarter financial results
Cybin announced the unaudited financial results of Clarmin Explorations Inc. (now Cybin Inc.) for the three-month period ended October 31, 2020.